Vivos Therapeutics(VVOS) - 2024 Q3 - Quarterly Results

Exhibit 99.1 Vivos Therapeutics Reports Third Quarter 2024 Financial Results and Provides Operational Update Revenue Increased 17% Quarter over Quarter Operating Loss Decreased 27% Management to Host Conference Call Today at 5:00 pm ET LITTLETON, Colo., November 14, 2024 – Vivos Therapeutics, Inc. ("Vivos" or the "Company'') (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related breath ...